Remifentanil dose for laryngeal mask airway insertion with a single standard dose of propofol during emergency airway management in elderly patients

Korean Journal of Anesthesiology 2014³â 66±Ç 4È£ p.278 ~ p.282

À¯Á¤Èñ(Ryu Jung-Hee) - Seoul National University Bundang Hospital Department of Anesthesiology and Pain Medicine
¿À¾Æ¿µ(Oh Ah-Young) - Seoul National University Bundang Hospital Department of Anesthesiology and Pain Medicine
(Baek Ji-Seok) - Seoul National University Bundang Hospital Department of Anesthesiology and Pain Medicine
±èÁøÈñ(Kim Jin-Hee) - Seoul National University Bundang Hospital Department of Anesthesiology and Pain Medicine
¹Ú»óÇå(Park Sang-Heon) - Seoul National University Bundang Hospital Department of Anesthesiology and Pain Medicine
(Noh Jae-Mun) - Seoul National University Bundang Hospital Department of Anesthesiology and Pain Medicine

Abstract

Background: This study determined the dose of remifentanil to use during insertion of a Classic¢â laryngeal mask airway (LMA, The Laryngeal Mask Co., Nicosia, Cyprus) in elderly patients during emergency airway management when combined with a single dose of propofol.

Methods: Patients aged 65-80 years were enrolled. Anesthesia was induced with propofol 1 mg/kg, and then a blinded dose of remifentanil was infused over 30 s after confirming the patient¡¯s loss of consciousness. The dose of remifentanil was determined using Dixon¡¯s up-and-down method, starting at 0.5 ¥ìg/kg (a step size of 0.1 ¥ìg/kg). Insertion of the LMA was attempted 60 s after loss of consciousness.

Results: In total, 23 patients were recruited and the mean age ¡¾ standard deviation was 72 ¡¾ 3 years. The effective dose for successful LMA insertion in 50% of the patients (ED50) was 0.20 ¡¾ 0.05 ¥ìg/kg. No patient needed more than 0.3 ¥ìg/kg.

Conclusions: Remifentanil 0.20 ¡¾ 0.05 ¥ìg/kg with propofol 1 mg/kg resulted in excellent LMA insertion in 50% of elderly patients without significant hemodynamic changes during emergency airway management.

Ű¿öµå

Aged, Laryngeal mask airway, Remifentanil
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå